The Plasmid DNA Manufacturing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for plasmid DNA manufacturing has seen significant growth recently. The market will expand from $2.34 billion in 2024 to $2.9 billion in 2025, marking a compound annual growth rate (CAGR) of 23.9%.
The Plasmid DNA Manufacturing market is projected to reach $6.78 billion in 2029, with a compound annual growth rate (CAGR) of 23.6%.
Download Your Free Sample of the 2025 Plasmid DNA Manufacturing Market Report and Uncover Key Trends Now!The drivers in the plasmid dna manufacturing market are:
• Application of plasmid DNA in industrial processes
• Use of plasmid DNA for creating genetically modified organisms
• Production of monoclonal antibodies with plasmid DNA in cell lines
• Utilization of plasmid DNA in the realm of bioremediation and environmental applications.
The plasmid DNA manufacturing market covered in this report is segmented –
1) By Grade: Research And Development Grade, Good Manufacturing Practice (GMP) Grade
2) By Development Phase: Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics
3) By Disease: Infectious Disease, Cancer, Genetic Disorder, Other Diseases
4) By Application: Deoxyribonucleic Acid (DNA) Vaccines, Cell And Gene Therapy, Immunotherapy, Other Applications
The trends in the plasmid dna manufacturing market are:
• There is an increase in the use of plasmid DNA for the development of DNA vaccines and personalized therapies.
• Plasmid DNA technologies are seeing increased licensing activity and the creation of customized solutions.
• There is a shift towards high-throughput screening and scalable manufacturing solutions.
• Strategies to reduce costs are emerging in the market trends.
The major players in the plasmid dna manufacturing market are:
• Thermo Fisher Scientific Inc.
North America was the largest region in the plasmid DNA manufacturing market in 2023